SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wanbury informs about press release

25 Jan 2024 Evaluate

Wanbury has informed that it enclosed a Press Release on Q3 & 9M F24 Financial Results.

The above information is a part of company’s filings submitted to BSE.

Wanbury Share Price

256.90 -17.05 (-6.22%)
07-Aug-2026 14:53 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1940.35
Dr. Reddys Labs. 1167.90
Cipla 1470.00
Lupin 2365.70
Zydus Lifesciences 1115.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: